🇺🇸 FDA
Patent

US 8664177

Peptide compositions and methods for treating patients

granted A61KA61K38/06A61P

Quick answer

US patent 8664177 (Peptide compositions and methods for treating patients) held by THE REGENTS OF THE UNIVERSITY OF MICHIGAN expires Mon Feb 27 2034 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
THE REGENTS OF THE UNIVERSITY OF MICHIGAN
Grant date
Tue Mar 04 2014 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Feb 27 2034 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
9
CPC classes
A61K, A61K38/06, A61P, A61P3/00, A61P3/04